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Abstract: Concentrations of main bronchoconstricting chemical mediators, histamine
and leukotriene C 4 (LTC 4), were measured in bronchoalveolar lavage (SAL) fluid,
and when cells (peripheral leukocytes and SAL cells) were stimulated by Ca ionophore
A23187, in 7 atopic and 7 nonatopic asthma patients. 1. The proportion of
basophilic cells was significantly larger in atopic than in nonatopic asthma (p<O.05),
however no significant difference was present in the other BAL cells between the two
asthma types. 2. Concentration of histamine in SAL fluid was significantly higher in
atopic than that in nonatopic asthma, however, difference in that of LTC 4 was not
found between them. 4. The release of LTC 4 from SAL cells was higher in nonatopic
than that in atopic asthma, but this was not significant. In contrast, the release of
histamine was significantly higher in atopic compared to that in nonatopic asthma
(p<O.OO1) when the cells were stimulated by Ca ionophore A23187.
These results suggest that both histamine and LTC 4 participate in the onset
mechanism of atopic asthma, and only LTC 4 in that of nonatopic asthma.
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Introduction
Bronchial asthma is divided into two types,
atopic and nonatopic, based on the presence
or absence of IgE - mediated allergic react-
ion'). Atopic asthma is often observed in
younger patients and nonatopic in older
patients. Our previous studies have shown
that the role of histamine during triggering
events of asthma attacks is different between
younger and older patients with asthma 2).
In atopic asthma, bridging of IgE receptors
on mast cell membrane is caused by allergen,
followed by release of chemical mediators
such as histamine and leukotriene C 4
(LTC 4 )3-7). These mediators, especially
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histamine, induce pathophysiological changes
of airways such as bronchoconstriction, mu-
cus hypersecretion and edema of mucous
membreane. Thus, histamine is one of the
most important mediators relating to the
onset mechanisms of atopic asthma attacks.
In contrast, the onset mechanism of
nonatopic asthma is still unclear in relation
to participation allergic reactions.
Leukotriene C 4 is also one of the chemical
mediators having bronchoconstricting action
and participates in the onset mechanisms of
asthma attacks. However, it is not well
known in what kind of asthma attacks
LTC 4 predominantly participates.
This study was performed to clarify the
difference in action of histamine and LTC 4
during onset periods of attacks between
atopic and nonatopic asthma.
Subjects and methods
The subjects were 7 patients (4 females
and 3 males) with atopic asthma and 7 ( 4
females and 3 males) with nonatopic
asthma. All subjects with atopic asthma
showed positive RAST score for house dust
mite (HDm). In contrast, patients with
negative RAST score for inhalant allergens
and low levels of serum IgE (less than 200 I
U/ mR) were evaluated as those with
nonatopic asthma. Characteristic of these
patients was shown in Table 1.
Tabel 1 . Characteristics of patients with
bronchial asthma studied
Asthma No of Age Serum IgE
type patients (years) (IU/m!) FEV1.0%
Atopic 7 52.3 455 65.7
(198-1057) ± 9.5
nonatopic 7 52.0 91 62.9
(18-174) ± 3.1
Histamine content III bronchoalveolar
lavage (BAL) fluid, from peripheral leuko-
cytes and BAL cells stimulated by Ca
ionophore A23187, was analyzed by perchloric
acid precipitation and analyzed with an spec-
trofluorometric analysis system (Technicon
Instruments Co.), as previously described B- 10).
The release of histamine from peripheral
leukocytes stimulated by Ca ionophore
A23187 was observed by a whole blood
method, as previously reported. Regarding
the release of histamine from BAL cells, Ca
ionophore A23187 (1 j1. g/m£) was added to
the cell suspension, after the number of BAL
cells was adjusted to 10 6 cells/ mR in Tris
ACM. The mixed solution was then incubated
for 15 min at 37 cC and centrifuged at 300g
for 10 min at 4 cC. Histamine release was
expressed as a percentage of total histamine.
The HPLC analysis for extraction and
quantification of leukotriene C 4 (LTC 4 ) was
performed by a method by Lam et a16, 11). The
extraction of LTC 4 was performed using a
CIS Seppak (walters Associates). The concen-
tration of LTC 4 was analyzed by an HPLC
system, Model 510 (Walters Associates),
equipped with an ultravioletdetector. The
column used was a 5 mID xlOcm Radial-Pak
cartridge (Shimazu). The results were ex-
pressed as ng/10 6 cells.
Bronchoalveolar lavage (BAL) was per-
formed according to the method previously
described1H5). Informed consent for BAL
examination was accepted by all subjects.
After the aspirate were centrifuged at 300g
for 10 min at 4 °C, the cell pellet was
resuspended in Tris ACM. BAL cytology was
performed by observing 500 cells, excluding
epithelial cells, on smear preparations which
were made from BAL cell suspensions and
stained with May-Giemsa. Regarding mast
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cells and basophils in BAL fluid, 1000 cells
were observed and number of basophilic cells
was calculated. In this study, the mean recov-
ery rate at BAL was 31.4% in atopic and
25.3% in nonatopic asthma.
The level of total IgE in sera was measured
by radioimmunosorbent test (RIST) and IgE
antibodies for inhalant allergens were esti-
mated by radioallergosorbent test (RAST).
Table 2. Cellular composition of BAL flu-
id of atopic and nonatopic asthma
Asthma Recovery No of total SAL cells (%)
type rate (%) cells (x 1 0 6) Mac Lymph Neut Eos Bas
Atopic 31,4 8,4 75.8 16.0 2.5 5.5 a0.25
±19.8 ±4.2 ±11.1 ±9,4 ±3.3 ±9,4 ±0.Z7
Non- 25.3 7,4 77.4 , 8.9 2.1 0.9 a0.02
atopic ± 4.6 ± 1.7 ± 7.8 ±8.0 ±2.6 ± 1.0 ±0.03
Results
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Fig. 2 Histamine release from peripheral
leucocytes in atopic and nonatopic
asthma
2. Histamine release
%Histamine release from peripheral leu-
kocytes was higher in atopic (26.0 ± 15.9%)
than in nonatopic asthma (16.8 ± 3.7%), but
this was not significant (Fig. 2 ).
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Histamine content in BAL fluid was signifi-
cantly higher in atopic than in nonatopic
asthma patients (p<O.OOl), in whom hista-
mine was not detectable by a fluorometric
method (Table 3).
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Fig. 1 Absolute counts of eosinophils and
basophilic cells in BAL fluid of atopic
(.) and nonatopopic asthma (~).
1. Bronchoalveolar lavage (BAL) cells
Table 2 shows the proportion of BAL
cells in atopic and nonatopic asthma pa-
tients. The proportion of basophilic cells was
significantly higher in atopic compared to
that in nonatopic asthma (p<0.05). The
proportions of the other BAL cells were not
significantly different between two asthma
types.
Regarding absolute counts of eosinophils and
basophilic cells, the number of the two BAL
cells was larger in atopic than in nonatopic,
however, these differences were not signifi-
cant (Fig. 1 ).
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Table 3. Concentrations of histamine and
LTC 4 in BAL fluid of atopic
and nonatopic asthma
ng/10 6 cells), however, this was not signifi-
cant (Fig. 3)
Discussion
Fig.3 LTC 4 and histamine release from
BAL cells in atopic (e) and
nonatopic (l§l) asthma. a:p<O.OOl.
As shown III Fig. 3, histamine release from
BAL cells was also significantly higher in
atopic compared to the release III nonatopic
asthma (p<O.OOl)
3. Leukotriene C 4 release
LTC 4 content was higher III nonatopic
than in atopic asthma, however, significant
difference was not present between them
(Table 3.). In contrast, LTC 4 release from
BAL cells was observed when the cells were
stimulated by Ca ionophore A231877, and the
release was higher in nonatopic (13.0 ± 4.6ng
/10 6 cells) than in atopic asthma (9.1 ±6.2
Nonatopic
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Bronchial asthma is classified into two
types, atopic and nonatopic, based on the
presence or absence of IgE-mediated allergic
reaction. However, despite of the presence or
absence of IgE-mediated reaction, chemical
mediators such as histamine and LTC 4 ,
which are released from tissue mast cells
during the time of immediate asthmatic
reaction OAR), and from inflammatory cells
during late asthmatic reaction (LAR), play
an important role in the onset mechanisms of
asthma attacks16- 111 ). In recent years, many
kinds of antiallergic drugs inhibiting actions
of histamine and LTC 4 have been developed.
Thus, it is very important for physicians to
know roles of chemical mediators such as
histamine and LTC 4 in asthma attacks of
each patient.
We carried out the present study to clarify
that the way in which the release of chemical
mediators, histamine and LTC 4, from BAL
cells in asthma patients are different between
the two asthma types, atopic and nonatopic.
Thus, the release of histamine and LTC 4 was
observed III the airways of atopic and
nonatopic asthma patients. Regarding inflam-
matory cells in the airways, the proportion
of basophilic cells was significantly higher in
atopic than in nonatopic asthma. It has been
noted that activated T cells and eosinophils
participate III the onset mechanisms of
asthma attacks19) and furthermore, it has been
suggested that neutrophils in the airways
may be related to asthma attacks211,2J). How-
ever, the proportions of the other BAL cells
except basophilic cells were not different
between the two asthma types. The results
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relating to the release of chemical mediators
showed that histamine largely participates in
attacks of patients with atopic asthma.
However, histamine seemed not to be related
to attacks of patients with nonatopic
asthma. LTC 4, which has strong action
inducing bronchospasm mainly during LAR,
was significantly released from BAL cells of
both atopic and nonatopic asthmatics when
the cells were stimulated with Ca ionophore
A23187, and the release was higher in
nonatopic than III atopic asthma, although
this difference was not significant. These
results suggest that LTC 4 induce pathop-
hysiological changes including bronchospasm
in the airways of both atopic and nonatopic
asthma patients. In application of anti-
allergic agents for the treatment of asthma,
drugs inhibiting actions of histamine and/or
LTC 4 should be selected in atopic asthma,
drugs mainly inhibiting action of LTC 4 in
nonatopic asthma.
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アトピー型および非アトピー型気管支嘱息の発作
発症機序の差異について･･ロイコトリエンC4の
役割について
芦田耕三,御船尚志,光延文裕,保崎泰弘,
横田 聡,柘野浩史,谷崎勝朗
岡山大学医学部付属病院三朝分院内科
気管支瞭息患者14人(アトピー型,非アトピー型
各7人)につき気管支肺胞洗浄(BAL)液及び気管
支肺胞洗浄細胞と末梢血白血球をカルシウムイオ
ノファA23187で刺激し,主要な気管支収縮メディ
エーターであるヒスタミンとロイコトリエンC4
(LTC4)の濃度を測定した｡1,BAL中細胞の比
27
率では好塩基球のみ非アトピー型に比べアトピー
型で優位に高い値であった｡(p<0.05)
2.BAL液のヒスタミンの濃度はアトピー型で有
意に高い値であったが,ロイコトリエンC4はア
トピー型,非アトピー型で有意な差を認めなかっ
た｡3.BAL細胞からのカルシウムイオノファA
23187刺激によるロイコトリエンC4産生はアト
ピー型に比べ非アトピー型で高い値であったが,
有意差は認めなかった｡一方,同刺激によるヒス
タミン遊離は非アトピー型よりアトピー型で有意
に高値であった｡(p<0.001)｡以上の結果よりア
トピ-型の気管支瑞息の発症機序にはヒスタミン,
ロイコトリエンC4の両者が,非アトピー型に於
いてはロイコトリエンC4のみが主として関与 し
ていること可能性が示唆された｡
